Cleared Traditional

K830688 - COMBION SKIN TEST

K830688 is an FDA 510(k) clearance for COMBION SKIN TEST, manufactured by Nicholas H. Maganias. The device is a Class 1 Immunology device with product code LKH cleared through the Traditional 510(k) pathway after a 27-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1983
Decision
27d
Days
Class 1
Risk

K830688 is an FDA 510(k) clearance for the COMBION SKIN TEST. Classified as Antisera, Immunoperoxidase, Chlamydia Spp. (product code LKH), Class I - General Controls.

Submitted by Nicholas H. Maganias (Mchenry, US). The FDA issued a Cleared decision on March 31, 1983 after a review of 27 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.3120 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K830688

510(k) Number K830688 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 1983
Decision Date March 31, 1983
Days to Decision 27 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d faster than avg
Panel avg: 105d · This submission: 27d
Pathway characteristics
Predicate-based equivalence.

LKH Device Classification - Class 1, General Controls

Product Code LKH Antisera, Immunoperoxidase, Chlamydia Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3120
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - LKH Antisera, Immunoperoxidase, Chlamydia Spp.

All 7
Devices cleared under the same product code (LKH) and FDA review panel - the closest regulatory comparables to K830688.
CELLMATICS SHLAMYDIA DETECTION SYSTEM
K893669 · Difco Laboratories, Inc. · Jun 1989
SELECTICULT-CHLAMYDIA
K852869 · Scott Laboratories, Inc. · Sep 1985
CHLAMYDIAE IMMUNOPEROXIDASE TEST KIT
K842151 · Bartels Immunodiagnostic Supplies, Inc. · Jul 1984
HISTOSET IMMUNOPEROXIDASE TISSURE KIT
K820390 · Immulok, Inc. · Apr 1982